Letter

Trophoblastic disease

Analytical problems associated with HCG assay

BMJ 2008; 337 doi: 10.1136/bmj.a2076 (Published 13 October 2008)
Cite this as: BMJ 2008;337:a2076

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Julian H Barth, consultant chemical pathologist1
  1. 1Leeds General Infirmary, Leeds LS1 3EX
  1. julian.barth{at}leedsth.nhs.uk

    Sebire and Seckl state that gestational trophoblastic disease is monitored by measuring serum human chorionic gonadotrophin (HCG), but they do not discuss the analytical problems associated with this assay.1

    Numerous reports of interference with this assay have been made since 1984, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular